Cite
HARVARD Citation
Yuen, M. et al. (2020). Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial. Lancet gastroenterology and hepatology. pp. 152-166. [Online].